Online First
University of Pennsylvania researchers have shortened the cell manufacturing process for CAR T-cell therapy, which is ...
Researchers inactivated thousands of genes in several adult T-cell leukemia/lymphoma cell lines and found CDK6 to be a ...
NK Cells Complexed with Bispecific Antibody Active in Advanced Lymphoma
Advertisement
The FDA has put a partial hold on a clinical trial of emavusertib after the death of a patient.
The designation is for patients with relapsed or refractory acute myeloid leukemia.
Axicabtagene celoleucel (axi-cel) CAR T-cell therapy is now an initial treatment option for adults with refractory or ...
Advertisement
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion ...
WU-CART-007 is being tested as part of a phase 1/2 trial to evaluate if off-the-shelf therapy is safe and feasible.
After a meeting with the U.S. Food and Drug Administration (FDA) the manufacturers of zandelisib – MEI Pharma and Kyowa ...
New legislation would set time limits around FDA accelerated approvals.
The designation was granted to ex vivo investigational T-cell receptor therapy NTLA-5001.
The FDA has accepted the sNDA for ivosidenib tablets as a proposed treatment for previously untreated IDH1-mutated AML.
The FDA has published draft recommendations for potential manufacturers of gene therapy products.
Mocravimod is a sphingosine 1 phosphate receptor modulator.
The FDA has granted accelerated approval to pacritinib for the treatment of adult patients with intermediate or high-risk.
Many side effects of the COVID-19 pandemic have disproportionately impacted older Americans.
According to a recent HHS report, the percentage of uninsured Black Americans has decreased since the ACA became law in 2010.
Oxford Biodynamics has announced the US launch of the clinical blood test.
Cilta-cel has been approved by the FDA for the treatment of patients with relapsed or refractory multiple myeloma who have ...
The EU proposed the first international regulation for artificial intelligence.
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.